-
Something wrong with this record ?
Synthesis and anthelmintic activity of benzopyrano[2,3-c]pyrazol-4(2H)-one derivatives
V. Milišiūnaitė, A. Kadlecová, A. Žukauskaitė, K. Doležal, M. Strnad, J. Voller, E. Arbačiauskienė, W. Holzer, A. Šačkus
Language English Country Netherlands
Document type Journal Article
Grant support
IGA_PrF_2019_020
Internal Grant Agency of Palacký University
CZ.02.1.01/0.0/0.0/16_019/0000868
Ministry of Education, Youth and Sports of the Czech Republic
LTC17072
Ministry of Education, Youth and Sports of the Czech Republic
P40 OD010440
ODCDC CDC HHS - United States
PP-91B/19
Research, Development and Innovation Fund of Kaunas University of Technology
P40 OD010440
ODCDC CDC HHS - United States
NLK
ProQuest Central
from 1997-03-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2011-02-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-03-01 to 1 year ago
- MeSH
- Anthelmintics chemical synthesis pharmacology MeSH
- Cell Line MeSH
- Caenorhabditis elegans drug effects MeSH
- Cyclization drug effects MeSH
- Larva drug effects MeSH
- Humans MeSH
- Pyrazoles chemistry MeSH
- Structure-Activity Relationship MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
A series of benzopyrano[2,3-c]pyrazol-4(2H)-one derivatives were synthesized from readily available 1-phenyl- and 1-methyl-1H-pyrazol-3-ols by sequentially employing O-acylation, Fries rearrangement and potassium carbonate-induced cyclization. The anthelmintic properties of the obtained compounds were investigated in vivo in a model nematode, Caenorhabditis elegans. Five compounds, namely 2-phenyl[1]benzopyrano[2,3-c]pyrazol-4(2H)-one 33 and its 7-fluoro, 7-chloro-, 7-bromo- and 8-fluoro-analogues, 36, 38, 40 and 43, respectively, altered the development of C. elegans. While the activities of 33 and 43 were rather modest, compounds 36, 38 and 40 inhibited the growth of the worms at concentrations of approximately 1-3 µM. At these concentrations, the compounds did not kill the worms, but they strongly inhibited their development, with the majority of larvae never progressing past the L1 stage. Moreover, testing in non-cancer human cell lines showed that, with exception of 7-bromo derivative 40, the active compounds have favourable toxicity profiles.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026459
- 003
- CZ-PrNML
- 005
- 20211026132907.0
- 007
- ta
- 008
- 211013s2020 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11030-019-10010-3 $2 doi
- 035 __
- $a (PubMed)31713185
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Milišiūnaitė, Vaida $u Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, 50254, Kaunas, Lithuania
- 245 10
- $a Synthesis and anthelmintic activity of benzopyrano[2,3-c]pyrazol-4(2H)-one derivatives / $c V. Milišiūnaitė, A. Kadlecová, A. Žukauskaitė, K. Doležal, M. Strnad, J. Voller, E. Arbačiauskienė, W. Holzer, A. Šačkus
- 520 9_
- $a A series of benzopyrano[2,3-c]pyrazol-4(2H)-one derivatives were synthesized from readily available 1-phenyl- and 1-methyl-1H-pyrazol-3-ols by sequentially employing O-acylation, Fries rearrangement and potassium carbonate-induced cyclization. The anthelmintic properties of the obtained compounds were investigated in vivo in a model nematode, Caenorhabditis elegans. Five compounds, namely 2-phenyl[1]benzopyrano[2,3-c]pyrazol-4(2H)-one 33 and its 7-fluoro, 7-chloro-, 7-bromo- and 8-fluoro-analogues, 36, 38, 40 and 43, respectively, altered the development of C. elegans. While the activities of 33 and 43 were rather modest, compounds 36, 38 and 40 inhibited the growth of the worms at concentrations of approximately 1-3 µM. At these concentrations, the compounds did not kill the worms, but they strongly inhibited their development, with the majority of larvae never progressing past the L1 stage. Moreover, testing in non-cancer human cell lines showed that, with exception of 7-bromo derivative 40, the active compounds have favourable toxicity profiles.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a anthelmintika $x chemická syntéza $x farmakologie $7 D000871
- 650 _2
- $a Caenorhabditis elegans $x účinky léků $7 D017173
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a cyklizace $x účinky léků $7 D003500
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a larva $x účinky léků $7 D007814
- 650 _2
- $a pyrazoly $x chemie $7 D011720
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kadlecová, Alena $u Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Science, Palacký University, Šlechtitelů 27, 78371, Olomouc, Czech Republic
- 700 1_
- $a Žukauskaitė, Asta $u Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Science, Palacký University, Šlechtitelů 27, 78371, Olomouc, Czech Republic
- 700 1_
- $a Doležal, Karel $u Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Science, Palacký University, Šlechtitelů 27, 78371, Olomouc, Czech Republic $u Department of Chemical Biology and Genetics, Faculty of Science, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 27, 78371, Olomouc, Czech Republic
- 700 1_
- $a Strnad, Miroslav $u Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Science, Palacký University, Šlechtitelů 27, 78371, Olomouc, Czech Republic
- 700 1_
- $a Voller, Jiří $u Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Science, Palacký University, Šlechtitelů 27, 78371, Olomouc, Czech Republic
- 700 1_
- $a Arbačiauskienė, Eglė $u Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, 50254, Kaunas, Lithuania. egle.arbaciauskiene@ktu.lt
- 700 1_
- $a Holzer, Wolfgang $u Division of Drug Synthesis, Department of Pharmaceutical Chemistry, University of Vienna, Althanstrasse 14, 1090, Vienna, Austria
- 700 1_
- $a Šačkus, Algirdas $u Institute of Synthetic Chemistry, Kaunas University of Technology, K. Baršausko g. 59, 51423, Kaunas, Lithuania. algirdas.sackus@ktu.lt
- 773 0_
- $w MED00007776 $t Molecular diversity $x 1573-501X $g Roč. 24, č. 4 (2020), s. 1025-1042
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31713185 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026132913 $b ABA008
- 999 __
- $a ok $b bmc $g 1715241 $s 1146966
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 24 $c 4 $d 1025-1042 $e 20191111 $i 1573-501X $m Molecular diversity $n Mol Divers $x MED00007776
- GRA __
- $a IGA_PrF_2019_020 $p Internal Grant Agency of Palacký University
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_019/0000868 $p Ministry of Education, Youth and Sports of the Czech Republic
- GRA __
- $a LTC17072 $p Ministry of Education, Youth and Sports of the Czech Republic
- GRA __
- $a P40 OD010440 $p ODCDC CDC HHS $2 United States
- GRA __
- $a PP-91B/19 $p Research, Development and Innovation Fund of Kaunas University of Technology
- GRA __
- $a P40 OD010440 $p ODCDC CDC HHS $2 United States
- LZP __
- $a Pubmed-20211013